Evaluation of the Long-Term Impact on Quality After the End of Pharmacist-Driven Warfarin Therapy Management in Patients With Poor Quality of Anticoagulation Therapy (2020)
- Authors:
- Autor USP: KRIEGER, JOSE EDUARDO - FM
- Unidade: FM
- DOI: 10.3389/fphar.2020.01056
- Subjects: ANTICOAGULANTES; SERVIÇOS FARMACÊUTICOS; TEMPO
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Frontiers in pharmacology
- ISSN: 1663-9812
- Volume/Número/Paginação/Ano: v. 11, article ID 1056, 7p, 2020
- Este periódico é de acesso aberto
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: gold
- Licença: cc-by
-
ABNT
MARCATTO, Leiliane Rodrigues et al. Evaluation of the Long-Term Impact on Quality After the End of Pharmacist-Driven Warfarin Therapy Management in Patients With Poor Quality of Anticoagulation Therapy. Frontiers in pharmacology, v. 11, 2020Tradução . . Disponível em: https://doi.org/10.3389/fphar.2020.01056. Acesso em: 17 abr. 2024. -
APA
Marcatto, L. R., Sacilotto, L., Tavares, L. C., Souza, D. S. P., Olivetti, N. Q. S., Strunz, C. M. C., et al. (2020). Evaluation of the Long-Term Impact on Quality After the End of Pharmacist-Driven Warfarin Therapy Management in Patients With Poor Quality of Anticoagulation Therapy. Frontiers in pharmacology, 11. doi:10.3389/fphar.2020.01056 -
NLM
Marcatto LR, Sacilotto L, Tavares LC, Souza DSP, Olivetti NQS, Strunz CMC, Darrieux FCC, Scanavacca MI, Krieger JE, Pereira AC. Evaluation of the Long-Term Impact on Quality After the End of Pharmacist-Driven Warfarin Therapy Management in Patients With Poor Quality of Anticoagulation Therapy [Internet]. Frontiers in pharmacology. 2020 ; 11[citado 2024 abr. 17 ] Available from: https://doi.org/10.3389/fphar.2020.01056 -
Vancouver
Marcatto LR, Sacilotto L, Tavares LC, Souza DSP, Olivetti NQS, Strunz CMC, Darrieux FCC, Scanavacca MI, Krieger JE, Pereira AC. Evaluation of the Long-Term Impact on Quality After the End of Pharmacist-Driven Warfarin Therapy Management in Patients With Poor Quality of Anticoagulation Therapy [Internet]. Frontiers in pharmacology. 2020 ; 11[citado 2024 abr. 17 ] Available from: https://doi.org/10.3389/fphar.2020.01056 - Influência das variantes funcionais do gene da enzima conversora da angiotensina na progressão da insuficiência cardíaca
- Insuficiência das variantes gênicas do fator de necrose tumoral alfa na evolução de doentes com insuficiência cardíaca
- Genética, biologia molecular e insuficiência cardíaca
- Age dependent association between high sensitivity c-reative protein and tumor necrosis factor functional variants
- Systemic and cardiac neurohumoral control during early and late stage heart failure in A2A/A2C adrenoceptor to mice
- ACE gene variants and diseases progression in heart failure
- Polimorfismo genético da proteína C-reativa em indivíduos sem evidências de cardiopatia
- Analise histologica e molecular da fibrose miocardica em pacientes portadores de miocardiopatia dilatada de diferentes etiologias
- Dynamic regulation of MTHFR MRNA expression and C677t genotype in individuals submitted to CABG: evidence for a role of homocysteine metabolism after coronary surgery
- Angiotensin-converting enzyme gene deletion polymorphism modulation of onset of symptoms and survival rate of patients with heart failure
Informações sobre o DOI: 10.3389/fphar.2020.01056 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
